FY24 EPS consensus $10.85.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABBV:
- AbbVie reports Q3 adjusted EPS $3.00, consensus $2.91
- AbbVie raises FY24 adjusted EPS view to $10.90-$10.94 from $10.67-$10.87
- AbbVie small cell lung cancer treatment granted FDA orphan designation
- Notable companies reporting before tomorrow’s open
- M&A News: AbbVie (NYSE:ABBV) Will Acquire Aliada Therapeutics for $1.4B